首页> 外文期刊>Behavioural Brain Research: An International Journal >The effect of Alzheimer's disease and Parkinson's disease on olfaction: A meta-analysis
【24h】

The effect of Alzheimer's disease and Parkinson's disease on olfaction: A meta-analysis

机译:阿尔茨海默氏病和帕金森氏病对嗅觉的影响:荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Impaired sense of smell is one of the earliest clinical features in both Alzheimer's disease (AD) and Parkinson's disease (PD). A meta-analysis was performed on articles obtained from the PubMed database in order to determine what aspects of olfaction are affected in these two diseases. By applying strict criteria, we included a total of 81 studies meeting the following criteria: (1) patients had a clinical diagnosis of AD or PD; (2) patients were compared to a healthy control group; (3) patients and controls were age-matched; (4) olfactory function was assessed by means of a psychophysical olfactory test; (5) mean and standard deviation were reported.Results indicate that AD and PD patients are more impaired on odor identification and recognition tasks than on odor detection thresholds task. In addition, PD patients are more impaired on detection thresholds than AD patients. These results suggest that PD patients are more impaired on low-level perceptual olfactory tasks whereas AD patients are more strongly impaired on higher-order olfactory tasks involving specific cognitive processes. The effect appears more pronounced for AD than PD, which seem to be affected more homogeneously. In conclusion, olfactory identification and recognition appear as the most interesting candidates to be included in a battery to detect subclinical cases in AD. In parallel, detection thresholds should be included in such a battery for subclinical PD patients.
机译:嗅觉障碍是阿尔茨海默氏病(AD)和帕金森氏病(PD)的最早临床特征之一。对从PubMed数据库获得的文章进行了荟萃分析,以确定在这两种疾病中嗅觉的哪些方面受到影响。通过应用严格的标准,我们纳入了总计81项符合以下标准的研究:(1)患者具有AD或PD的临床诊断; (2)将患者与健康对照组进行比较; (3)患者和对照组年龄相匹配; (4)通过心理物理嗅觉测试评估嗅觉功能; (5)报告了均值和标准差。结果表明,AD和PD患者在气味识别和识别任务上比在气味检测阈值任务上受到的损害更大。另外,与AD患者相比,PD患者的检测阈值受损更大。这些结果表明,PD患者在低水平的嗅觉任务上受损更大,而AD患者在涉及特定认知过程的高阶嗅觉任务上受损更大。 AD的效果似乎比PD的效果更明显,PD的效果似乎更均匀。总之,嗅觉的识别和识别似乎是检测AD中亚临床病例的最有趣的候选药物。同时,亚临床PD患者的电池应包括检测阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号